BALTIMORE, MD—June 15, 2010—When is neoadjuvant chemo-radiation recommended for patients with colorectal cancer (CRC)?  What are the most important points of difference regarding CRC treatment planning in younger patients compared with older patients?  What are some best practices for clinicians who are trying to manage cancer cases when the patient is already a chronic drug addict?

Changes in CRC detection, treatment, and management make it imperative that clinicians stay abreast of guideline-based recommendations and develop processes for implementing evidence-based practice changes. Leading oncology experts Thomas H. Cartwright, MD, John L. Marshall, MD, and clinicians nationwide will discuss strategies for overcoming barriers in CRC care during a complimentary, consultative Community of Practice audioconference today.

Date: Tuesday, June 15, 2010
Time: 6:00 to 6:30 PM ET
To Join: E-mail info@med-iq.com

“There have been major advances in the care for patients with colorectal cancer, and although our patients are receiving better care, I think most oncologists would agree with me when I say that we can all do better,” said John L. Marshall, MD, Chief, Division of Hematology/Oncology at Georgetown University Hospital.

Faculty

	Thomas H. Cartwright, MD Co-Chairman, US Oncology GI Research Medical Oncologist Ocala Oncology Center Ocala, FL
	John L. Marshall, MD Professor of Medicine and Oncology Chief, Division of Hematology/Oncology Georgetown University Hospital Associate Director, Clinical Research Lombardi Comprehensive Cancer Center Washington, DC

“I look forward to sharing strategies with other specialists that will enable physicians to improve several areas of care for patients with CRC, specifically patient safety/supportive care measures, CRC surveillance, and the use of guideline- and evidence-based treatments,” said Thomas H. Cartwright, MD, Co-Chairman of US Oncology GI Research and faculty expert for the complimentary, certified performance improvement (PI) CME initiative, Performance Improvement Strategies in Colorectal Cancer.

This activity is part of the complimentary, certified PI CME series, Performance Improvement Strategies in Colorectal Cancer. PI CME has been recognized as an important component of a physician's continuing professional development and may answer multiple credentialing and reporting needs. Use your data from this PI CME series to complete ABIM's Self-Directed PIM and earn credit for ABIM Maintenance of Certification.

“This initiative offers oncology practices nationwide resources to self-assess, apply, and evaluate their current practice to optimize CRC patient care,” said Dr. Cartwright. To learn more about the educational resources available in this certified CME series, visit www.pi-iq.com/crc.

About Med-IQ

Med-IQ, America's most respected continuing medical education (CME) company, is an accredited provider of CME that educates and inspires healthcare professionals through programs that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. To learn more about us, visit www.Med-IQ.com.

For more information, contact:

Catherine B. Mullaney, MHA
Vice President, Educational Partnerships
Med-IQ
443 543 5101
info@med-iq.com